HP-hCG 1000IU by ZPHC is a peptide hormone commonly referenced in endocrine and reproductive research contexts. It is used in models involving hormonal regulation and testicular function support, particularly in scenarios where endogenous gonadotropin signaling is suppressed.

Active Ingredient and Dosage:
Each vial contains 1000 IU of human chorionic gonadotropin (hCG). The product comes in a pack of 5 vials, allowing flexible and controlled dosing in research applications.

Usage and Benefits:
hCG is studied for its role in mimicking luteinizing hormone (LH), which stimulates Leydig cells in the testes to produce testosterone. In research and clinical models, it is used to maintain or restore testicular function, support endogenous testosterone production, and prevent testicular atrophy during or after hormone suppression scenarios. It is also referenced in fertility-related protocols due to its role in supporting spermatogenesis.

Mechanism of Action:
hCG acts as an LH analog, binding to LH receptors in the testes to stimulate testosterone synthesis. This helps sustain testicular activity in conditions where natural LH secretion is reduced, such as during androgen suppression models. It is also involved in supporting intratesticular testosterone levels and reproductive hormone balance.

Product Features:
– Potency: 1000 IU per vial
– Presentation: 5-vial pack for flexible protocol design
– Injectable formulation for subcutaneous or intramuscular use after reconstitution
– Stable formulation designed for consistent biological activity
– Suitable for endocrine and reproductive research models

Key Benefits:
– Supports restoration of endogenous testosterone production
– Helps maintain testicular function during hormone suppression models
– May assist in preserving fertility parameters in research contexts
– Allows flexible dosing protocols based on study requirements

Recommended Use:
In research literature, hCG is commonly referenced in ranges of approximately 500–1000 IU every other day depending on protocol design and objective. Administration is typically subcutaneous or intramuscular after reconstitution, under controlled or supervised conditions.

Possible Side Effects:
– Headache or mild injection-site swelling
– Mood fluctuations in sensitive subjects
– Rare allergic reactions such as rash or itching
– Potential overstimulation of testicular tissue with excessive exposure

Contraindications:
Not recommended in individuals with hormone-sensitive cancers, prostate-related malignancies, or known hypersensitivity to hCG. Avoid use in pregnancy in clinical contexts unless medically indicated.

Storage Conditions:
Store in a cool, dry place protected from light. Refrigerate after reconstitution and follow stability guidelines.